• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0000950170-23-003068
    • amendment Flag false
    • auditor Firm Id 1,294
    • auditor Location Copenhagen, Denmark
    • auditor Name Deloitte Statsautoriseret Revisionspartnerselskab
    • cik 1,612,042
    • current Fiscal Year End Date --12-31
    • date Filed 2023-02-16
    • document Annual Report true
    • document Fiscal Period Focus FY
    • document Fiscal Year Focus 2,022
    • document Period End Date 2022-12-31
    • document Transition Report false
    • document Type 20-F
    • entity Address Address Line 1 Tuborg Boulevard 12
    • entity Address City Or Town Hellerup
    • entity Address Postal Zip Code DK-2900
    • entity Central Index Key 1,612,042
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-36815
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code G7
    • entity Interactive Data Current Yes
    • entity Name Ascendis Pharma A/S
    • entity Registrant Name Ascendis Pharma A/S
    • entity Shell Company false
    • entity Voluntary Filers No
    • entity Well Known Seasoned Issuer Yes
    • icfr Auditor Attestation Flag true
    • irs Number 0
    • period End 1,672,444,800,000
    • period Start 1,640,995,200,000
    • report Link https://www.sec.gov/Archives/edgar/data/1612042/000095017023003068/asnd-20221231_htm.xml
    • trading Symbol ASND
    • update 1970-01-01
    • id REPORTED_FINANCIALS
    • key ASND
    • subkey 20-F
    • date 2023-02-16
    • updated 2023-02-17
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

ASND stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0000950170-23-003068
  • amendment Flag false
  • auditor Firm Id 1,294
  • auditor Location Copenhagen, Denmark
  • auditor Name Deloitte Statsautoriseret Revisionspartnerselskab
  • cik 1,612,042
  • current Fiscal Year End Date --12-31
  • date Filed 2023-02-16
  • document Annual Report true
  • document Fiscal Period Focus FY
  • document Fiscal Year Focus 2,022
  • document Period End Date 2022-12-31
  • document Transition Report false
  • document Type 20-F
  • entity Address Address Line 1 Tuborg Boulevard 12
  • entity Address City Or Town Hellerup
  • entity Address Postal Zip Code DK-2900
  • entity Central Index Key 1,612,042
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-36815
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code G7
  • entity Interactive Data Current Yes
  • entity Name Ascendis Pharma A/S
  • entity Registrant Name Ascendis Pharma A/S
  • entity Shell Company false
  • entity Voluntary Filers No
  • entity Well Known Seasoned Issuer Yes
  • icfr Auditor Attestation Flag true
  • irs Number 0
  • period End 1,672,444,800,000
  • period Start 1,640,995,200,000
  • report Link https://www.sec.gov/Archives/edgar/data/1612042/000095017023003068/asnd-20221231_htm.xml
  • trading Symbol ASND
  • update 1970-01-01
  • id REPORTED_FINANCIALS
  • key ASND
  • subkey 20-F
  • date 2023-02-16
  • updated 2023-02-17